Patent: 10,071,158
✉ Email this page to a colleague
Summary for Patent: 10,071,158
| Title: | Combination of the application of antibodies for immunostimulation together with glucocorticoids |
| Abstract: | The present invention relates to methods for reducing or eliminating the non-specific release of a cytokine associated with a disease comprising administering at least one glucocorticoid and an immunostimulating antibody. Additionally, the present invention relates to a pharmaceutical composition that contains at least one immunostimulating antibody and at least one glucocorticoid. |
| Inventor(s): | Markus M. Heiss, Horst Lindhofer |
| Assignee: | Lindis Biotech GmbH |
| Application Number: | US14/247,029 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,071,158
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | BLINCYTO | blinatumomab | For Injection | 125557 | 3-Dec-14 | ⤷ Start Trial | 2034-04-07 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,071,158
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2606081 | ⤷ Start Trial |
| Denmark | 1874821 | ⤷ Start Trial |
| European Patent Office | 1874821 | ⤷ Start Trial |
| Spain | 2417065 | ⤷ Start Trial |
| Japan | 2008539177 | ⤷ Start Trial |
| Japan | 5129122 | ⤷ Start Trial |
| Poland | 1874821 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
